|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 35/44 | |
| A61K 39/00 | |||
| A61P 31/00 | |||
| A61P 33/00 | |||
| A61P 37/04 | |||
| A61P 39/00 | |||
| A61K 48/00 | |||
| C07K 14/08 | |||
| C07K 14/555 | |||
| C07K 16/10 | |||
| C12N 15/67 | |||
| C12N 15/85 | |||
| C12N 5/10 |
| (11) | Number of the document | 2288359 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09734792.6 |
| Date of filing the European patent application | 2009-04-20 | |
| (97) | Date of publication of the European application | 2011-03-02 |
| (45) | Date of publication and mention of the grant of the patent | 2019-10-02 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/CA2009/000528 |
| Date | 2009-04-20 |
| (87) | Number | WO 2009/129616 |
| Date | 2009-10-29 |
| (30) | Number | Date | Country code |
| 46630 P | 2008-04-21 | US |
| (72) |
ENNIS, Jane Elizabeth, CA
TURNER, Jeffrey Donald, CA
DAVIES, John Edward, CA
|
| (73) |
Tissue Regeneration Therapeutics Inc.,
790 Bay Street, Suite 512 P.O. Box 55, Toronto, Ontario M5G 1N8,
CA
|
| (54) | GENETICALLY MODIFIED HUMAN UMBILICAL CORD PERIVASCULAR CELLS FOR PROPHYLAXIS AGAINST OR TREATMENT OF BIOLOGICAL OR CHEMICAL AGENTS |
| GENETICALLY MODIFIED HUMAN UMBILICAL CORD PERIVASCULAR CELLS FOR PROPHYLAXIS AGAINST OR TREATMENT OF BIOLOGICAL OR CHEMICAL AGENTS |